Schroder Investment Management Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Hold
1,019,969
0.01% 647
2025
Q4
$13.5M Buy
1,019,969
+575,222
+129% +$7.38M 0.01% 591
2025
Q3
$5.75M Buy
+444,747
New +$5.94M ﹤0.01% 749
2025
Q1
Sell
-74,000
Closed -$2.23M 1248
2024
Q4
$2.23M Hold
74,000
﹤0.01% 910
2024
Q3
$1.16M Hold
74,000
﹤0.01% 1013
2024
Q2
$1.27M Hold
74,000
﹤0.01% 990
2024
Q1
$1.16M Hold
74,000
﹤0.01% 1002
2023
Q4
$1.1M Buy
+74,000
New +$990K ﹤0.01% 1000
2022
Q2
Sell
-3,732
Closed -$314K 1366
2022
Q1
$314K Buy
3,732
+1,367
+58% +$101K ﹤0.01% 1267
2021
Q4
$178K Hold
2,365
﹤0.01% 1254
2021
Q3
$275K Hold
2,365
﹤0.01% 1292
2021
Q2
$524K Buy
2,365
+755
+47% +$147K ﹤0.01% 1216
2021
Q1
$213K Sell
1,610
-55,288
-97% -$8.75M ﹤0.01% 1317
2020
Q4
$9.85M Buy
+56,898
New +$7.79M 0.01% 636

Other funds holding NVCR